Lipopolysaccharide-binding protein: A valuable biomarker in the differentiation between periprosthetic joint infection and aseptic loosening?

International Orthopaedics

Volumn 38, Issue 10, 2014, Pages 2201-2207

  Friedrich, Max J ^a   Randau, Thomas M ^a   Wimmer, Matthias D ^a   Reichert, Ben ^a   Kuberra, Dominik ^a   Stoffel Wagner, Birgit ^a   Wirtz, Dieter C ^a   Gravius, Sascha ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Arthroplasty; Aseptic loosening; Biomarkers; Diagnostics; Infection; Lipopolysaccharide binding protein; Periprosthetic joint infection

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARRIER PROTEIN; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN;

ADVERSE EFFECTS; AGED; BLOOD; FEMALE; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROSPECTIVE STUDY; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; REOPERATION; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARRIER PROTEINS; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; REOPERATION; SENSITIVITY AND SPECIFICITY;

EID: 84929269895     PISSN: 03412695     EISSN: 14325195     Source Type: Journal    
DOI: 10.1007/s00264-014-2351-9     Document Type: Article

References (37)

1. Trampuz A, Zimmerli W (2005) New strategies for the treatment of infections associated with prosthetic joints. Curr Opin Investig Drugs 6:185–190
2. Frommelt L (2004) Guidelines on antimicrobial therapy in situations of periprosthetic THR infection. Orthopade 33:822–828. doi:10.1007/s00132-004-0677-5
3. Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351:1645–1654. doi:10.1056/NEJMra040181
4. Berbari E, Mabry T, Tsaras G, Spangehl M, Erwin PJ, Murad MH, Steckelberg J, Osmon D (2010) Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg Am Vol 92:2102–2109. doi:10.2106/JBJS.I.01199
5. Deirmengian C, Hallab N, Tarabishy A, Della Valle C, Jacobs JJ, Lonner J, Booth RE Jr (2010) Synovial fluid biomarkers for periprosthetic infection. Clin Orthop Relat Res 468:2017–2023. doi:10.1007/s11999-010-1298-4
6. Gollwitzer H, Dombrowski Y, Prodinger PM, Peric M, Summer B, Hapfelmeier A, Saldamli B, Pankow F, von Eisenhart-Rothe R, Imhoff AB, Schauber J, Thomas P, Burgkart R, Banke IJ (2013) Antimicrobial peptides and proinflammatory cytokines in periprosthetic joint infection. J Bone Joint Surg Am Vol 95:644–651. doi:10.2106/JBJS.L.00205
7. Glehr M, Friesenbichler J, Hofmann G, Bernhardt GA, Zacherl M, Avian A, Windhager R, Leithner A (2013) Novel biomarkers to detect infection in revision hip and knee arthroplasties. Clin Orthop Relat Res 471:2621–2628. doi:10.1007/s11999-013-2998-3
8. Hundric-Haspl Z, Pecina M, Haspl M, Tomicic M, Jukic I (2006) Plasma cytokines as markers of aseptic prosthesis loosening. Clin Orthop Relat Res 453:299–304. doi:10.1097/01.blo.0000229365.57985.96
9. Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CG (2011) New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res 469:2992–2994. doi:10.1007/s11999-011-2102-9
10. Gollwitzer H, Diehl P, Gerdesmeyer L, Mittelmeier W (2006) Diagnostic strategies in cases of suspected periprosthetic infection of the knee. A review of the literature and current recommendations. Orthopade 35:904. doi:10.1007/s00132-006-0977-z, 906–908, 910–906
11. Ghanem E, Antoci V Jr, Pulido L, Joshi A, Hozack W, Parvizi J (2009) The use of receiver operating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty. Int J Infect Dis 13:e444–e449. doi:10.1016/j.ijid.2009.02.017
12. Parvizi J, Ghanem E, Menashe S, Barrack RL, Bauer TW (2006) Periprosthetic infection: what are the diagnostic challenges? J Bone Joint Surg Am Vol 88(Suppl 4):138–147. doi:10.2106/JBJS.F.00609
13. Toossi N, Adeli B, Rasouli MR, Huang R, Parvizi J (2012) Serum white blood cell count and differential do not have a role in the diagnosis of periprosthetic joint infection. J Arthroplast 27:51–54 e51. doi:10.1016/j.arth.2012.03.021
14. Atkins BL, Athanasou N, Deeks JJ, Crook DW, Simpson H, Peto TE, McLardy-Smith P, Berendt AR (1998) Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. J Clin Microbiol 36:2932–2939
15. Kobayashi N, Inaba Y, Choe H, Iwamoto N, Ishida T, Yukizawa Y, Aoki C, Ike H, Saito T (2009) Rapid and sensitive detection of methicillin-resistant Staphylococcus periprosthetic infections using real-time polymerase chain reaction. Diagn Microbiol Infect Dis 64:172–176. doi:10.1016/j.diagmicrobio.2009.01.033
16. Morawietz L, Classen RA, Schroder JH, Dynybil C, Perka C, Skwara A, Neidel J, Gehrke T, Frommelt L, Hansen T, Otto M, Barden B, Aigner T, Stiehl P, Schubert T, Meyer-Scholten C, Konig A, Strobel P, Rader CP, Kirschner S, Lintner F, Ruther W, Bos I, Hendrich C, Kriegsmann J, Krenn V (2006) Proposal for a histopathological consensus classification of the periprosthetic interface membrane. J Clin Pathol 59:591–597. doi:10.1136/jcp.2005.027458
17. Trampuz A, Hanssen AD, Osmon DR, Mandrekar J, Steckelberg JM, Patel R (2004) Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med 117:556–562. doi:10.1016/j.amjmed.2004.06.022
18. Weiss S, Geiss H, Kommerell M, Simank HG, Bernd L, Henle P (2006) Improving the diagnosis of septic arthritis by use of a pediatric blood culture system. Orthopade 35:456. doi:10.1007/s00132-005-0900-z, 458–462
19. Randau T, Friedrich M, Wimmer M, Reichert B, Kuberra D, Stoffel-Wagner B, Limmern A, Wirtz D, Gravius S (2014) IL-6 in serum and in synovial fluid enhances the differentiation between periprosthetic joint infection and aseptic loosening. PloS One Under Review
20. Janz V, Wassilew GI, Hasart O, Matziolis G, Tohtz S, Perka C (2013) Evaluation of sonicate fluid cultures in comparison to histological analysis of the periprosthetic membrane for detecting periprosthetic joint infection. Int Orthop 37:931–936. doi:10.1007/s00264-013-1853-1
21. Zweigner J, Schumann RR, Weber JR (2006) The role of lipopolysaccharide-binding protein in modulating the innate immune response. Microbes Infect/Institut Pasteur 8:946–952. doi:10.1016/j.micinf.2005.10.006
22. Geller DA, Kispert PH, Su GL, Wang SC, Di Silvio M, Tweardy DJ, Billiar TR, Simmons RL (1993) Induction of hepatocyte lipopolysaccharide binding protein in models of sepsis and the acute-phase response. Arch Surg 128:22–27, discussion 27–28
23. Schumann RR, Kirschning CJ, Unbehaun A, Aberle HP, Knope HP, Lamping N, Ulevitch RJ, Herrmann F (1996) The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol 16:3490–3503
24. Hallatschek W, Fiedler G, Kirschning CJ, Creutzburg F, Lamping N, Nussler A, Schumann RR (2004) Inhibition of hepatic transcriptional induction of lipopolysaccharide-binding protein by transforming-growth-factor beta 1. Eur J Immunol 34:1441–1450. doi:10.1002/eji.200324874
25. Zweigner J, Gramm HJ, Singer OC, Wegscheider K, Schumann RR (2001) High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 98:3800–3808
26. Wimmer MD, Randau TM, Petersdorf S, Pagenstert GI, Weisskopf M, Wirtz DC, Gravius S (2013) Evaluation of an interdisciplinary therapy algorithm in patients with prosthetic joint infections. Int Orthop 37:2271–2278. doi:10.1007/s00264-013-1995-1
27. Laffer RR, Graber P, Ochsner PE, Zimmerli W (2006) Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis 12:433–439. doi:10.1111/j.1469-0691.2006.01378.x
28. Krenn V, Morawietz L, Kienapfel H, Ascherl R, Matziolis G, Hassenpflug J, Thomsen M, Thomas P, Huber M, Schuh C, Kendoff D, Baumhoer D, Krukemeyer MG, Perino G, Zustin J, Berger I, Ruther W, Poremba C, Gehrke T (2013) Revised consensus classification. Histopathological classification of diseases associated with joint endoprostheses. Z Rheumatol 72:383–392. doi:10.1007/s00393-012-1099-0
29. Bozic KJ, Rubash HE (2004) The painful total hip replacement. Clin Orthop Relat Res 420:18–25
30. Bernard L, Lubbeke A, Stern R, Bru JP, Feron JM, Peyramond D, Denormandie P, Arvieux C, Chirouze C, Perronne C, Hoffmeyer P, Groupe D’Etude Sur LO (2004) Value of preoperative investigations in diagnosing prosthetic joint infection: retrospective cohort study and literature review. Scand J Infect Dis 36:410–416
31. Alijanipour P, Bakhshi H, Parvizi J (2013) Diagnosis of periprosthetic joint infection: the threshold for serological markers. Clin Orthop Relat Res 471:3186–3195. doi:10.1007/s11999-013-3070-z
32. Buttaro MA, Tanoira I, Comba F, Piccaluga F (2010) Combining C-reactive protein and interleukin-6 may be useful to detect periprosthetic hip infection. Clin Orthop Relat Res 468:3263–3267. doi:10.1007/s11999-010-1451-0
33. Parvizi J, McKenzie JC, Cashman JP (2012) Diagnosis of periprosthetic joint infection using synovial C-reactive protein. J Arthroplast 27:12–16. doi:10.1016/j.arth.2012.03.018
34. Piper KE, Fernandez-Sampedro M, Steckelberg KE, Mandrekar JN, Karau MJ, Steckelberg JM, Berbari EF, Osmon DR, Hanssen AD, Lewallen DG, Cofield RH, Sperling JW, Sanchez-Sotelo J, Huddleston PM, Dekutoski MB, Yaszemski M, Currier B, Patel R (2010) C-reactive protein, erythrocyte sedimentation rate and orthopedic implant infection. PLoS One 5:e9358. doi:10.1371/journal.pone.0009358
35. Branescu C, Serban D, Dascalu AM, Oprescu SM, Savlovschi C (2013) Interleukin 6 and lipopolysaccharide binding protein—markers of inflammation in acute appendicitis. Chirurgia 108:206–214
36. Pavare J, Grope I, Kalnins I, Gardovska D (2010) High-mobility group box-1 protein, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in children with community acquired infections and bacteraemia: a prospective study. BMC Infect Dis 10:28. doi:10.1186/1471-2334-10-28
37. Tsalkidou EA, Roilides E, Gardikis S, Trypsianis G, Kortsaris A, Chatzimichael A, Tentes I (2013) Lipopolysaccharide-binding protein: a potential marker of febrile urinary tract infection in childhood. Pediatr Nephrol 28:1091–1097. doi:10.1007/s00467-013-2432-9